News from Zyme and the companies we work with.
Fujifilm Rebrands Life Sciences Companies to Strengthen Position as Strategic Partners for Life, Offering End-to-End Solutions
FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a cell culture pioneer FUJIFILM Diosynth Biotechnologies will be known [...]
Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development
Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular interactions Collaboration allows researchers to progress rapidly from DNA [...]
Sapio Sciences Appoints Gordon McCall as Chief Operating Officer to Drive Global Operational Excellence
New role underscores Sapio’s commitment to operational excellence and elevating customer delivery across global markets Baltimore, MD, 27 May 2025 – Sapio Sciences, the science-aware™ lab informatics platform, today announced [...]
Closed Loop Medicine appoints Kate Woolland as CEO
Leadership transition to drive commercialization strategy in deploying and scaling proven platform and therapy-specific precision dosing technologies London, UK – May 20, 2025: Closed Loop Medicine Ltd. (“CLM”), a leader [...]
CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion Cambridge, UK, 20 May 2025: CN Bio, a leading provider of [...]
Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics
Lord David Prior appointed as Chair of the Board, previously Chairman of NHS England and member of the UK Life Sciences Council Sir Tony Kouzarides, Co-founder and Director, Milner Therapeutics [...]
Tozaro announces formation of Technical Advisory Board to support commercialization of Smart Polymers in cell and gene therapy bioprocessing
World-class experts from bioprocessing and cell and gene therapy (CGT) fields include Phil Vanek PhD, Carl Schoellhammer PhD, Daniel C. Smith PhD and Nick Clarkson D.Phil Bedfordshire, UK, 13 May [...]
PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics
Barbara Duncan joins as Chair and Stephen Dilly as Non-Executive Director Strategic appointments support progression of PhoreMost’s next generation degrader pipeline through preclinical development and commercialisation of its GlueSEEKER® platform [...]
Trilobio raises $8M to deliver whole lab automation for biologists
San Francisco, US, 06 May 2025: Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round [...]
PlaqueTec announces positive early research findings from interim analysis in BIOPATTERN trial
Pre-specified interim analysis reveals differences in protein concentration between systemic blood and blood from diseased coronary arteries Safety and functionality data for the updated Liquid Biopsy System supports continuation of [...]
Nuclera establishes distribution network across APAC and the Middle East
Operational expansion accelerates global distribution capability to increase regional access and technical support Multiple partnerships establish direct distribution channels in China, Japan, South Korea, Singapore and Israel Cambridge, UK, and [...]
Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector
Established biotech leader with over 20 years’ experience including at OXB and LifeArc driving commercialization to support CGT downstream manufacturing Michele Pedrocchi PhD appointed as Non-Executive Chair of the Board [...]
